Mainz Biomed Announces Stock Split

BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a 1-for-40 reverse stock split of its issued and outstanding shares. The reverse stock split was authorized by the Board of Directors of the Company pursuant to shareholder approval granted at its Extraordinary Shareholders Meeting on November 20, 2024.

Read the original post:
Mainz Biomed Announces Stock Split

Apogee Therapeutics Announces Agenda for Virtual R&D Day

SAN FRANCISCO and WALTHAM, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD) and other I&I indications, today announced the agenda for its upcoming virtual R&D Day being held on Monday, December 2, 2024 at 10:00 a.m. ET.

Read the original:
Apogee Therapeutics Announces Agenda for Virtual R&D Day

PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the "Notification Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders' equity. In the Company's Form 6-K dated November 13, 2024, the Company reported stockholders' equity of approximately $2,158,000 as of September 30, 2024.

More here:
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved an effective time at 12:01 a.m. Eastern Standard Time December 4, 2024, for its 1-for-33 reverse stock split. TransCode’s common stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market on December 4, 2024, under the current trading symbol, “RNAZ.” The reverse stock split was approved by TransCode’s stockholders and Board of Directors on November 22, 2024, and is intended to increase the per share trading price of the Company's common stock to enable the Company to meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market. There is no assurance that TransCode’s common stock will meet all Nasdaq requirements for continued listing.

Continued here:
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced the grant of an inducement option award to its newly appointed interim chief development officer, Daniel Baker, M.D. The grant was approved by a majority of the independent directors of the Company as inducement material to Dr. Baker entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) (“the Inducement Award”).

Continued here:
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Essential Lifestyle Changes to Manage Chronic Inflammation

Systemic inflammation affects how your body functions, often leading to a variety of health complications if left unaddressed. Taking proactive steps to manage inflammation can help you maintain better overall health and reduce the risk of chronic conditions. Understanding the factors that contribute to inflammation allows you to make informed decisions about lifestyle changes that can bring long-term benefits. By focusing on sustainable habits, you can improve your body’s ability to heal and perform at its best.

Understanding Systemic Inflammation

Inflammation is a natural response your body uses to heal injuries and fight infections. However, when inflammation becomes chronic, it can lead to systemic problems affecting your overall health. Persistent inflammation is linked to conditions such as heart disease, diabetes, arthritis, and even certain cancers. Addressing the causes and managing inflammation effectively can support long-term wellness and reduce the risk of chronic disease.

Changing Your Diet

An anti-inflammatory diet is one of the most effective ways to manage systemic inflammation. Include a variety of colorful fruits and vegetables, which are rich in antioxidants and essential nutrients. Add whole grains, lean proteins, and healthy fats like those found in nuts, seeds, and oily fish. Avoid processed foods, sugary drinks, and refined carbohydrates, as they can contribute to inflammation and worsen symptoms.

Managing Stress Levels

Chronic stress is a major contributor to inflammation and can significantly impact your physical and mental health. Practice mindfulness techniques like meditation or yoga to help lower stress hormones. Establish healthy boundaries in your personal and professional life to prevent feeling overwhelmed. Regularly take time for hobbies or relaxation activities to create a balanced state of mind and body.

Prioritizing Quality Sleep

Sleep plays a critical role in keeping inflammation under control and maintaining optimal health. Aim for seven to nine hours of restful sleep each night to allow your body time to repair itself. Establish a consistent sleep schedule, going to bed and waking up at the same time daily. Limit screen time and caffeine consumption before bedtime to enhance the quality of your rest.

Considering Alternative Ways to Address Inflammation

Consider exploring alternative methods to naturally support inflammation reduction in your body. Regular exposure to cold temperatures through cold therapy, such as ice baths or cryotherapy, may help lower inflammation. Herbal supplements such as turmeric, ginger, and boswellia are known for their anti-inflammatory properties. CBD products have shown promise in reducing inflammation and supporting overall wellness. Additionally, natural options like a THCa flower are gaining attention for their potential anti-inflammatory properties, offering another avenue for those seeking plant-based solutions.

Staying Active

Regular exercise is essential for reducing inflammation and promoting a healthy lifestyle. Engage in moderate activities like walking, swimming, or cycling for at least 30 minutes a day. Exercise helps regulate your immune system and lower inflammatory markers in your body. Remember to choose activities that you enjoy to create a sustainable fitness routine.

Keeping a Healthy Weight

Excess body weight can trigger and worsen inflammation throughout your body. Focus on a balanced diet and regular physical activity to achieve and maintain a healthy weight. Monitor portion sizes and opt for nutrient-dense meals instead of calorie-heavy options. A healthy weight can reduce stress on your joints and organs, improving overall inflammatory response.

Limiting Harmful Habits

Smoking and excessive alcohol consumption can increase inflammation and lead to other serious health issues. Avoid smoking altogether, as it directly damages tissues and worsens systemic inflammation. Moderate alcohol consumption to occasional, small amounts, or avoid it entirely for optimal health benefits. Replacing these habits with healthier alternatives can significantly reduce inflammation.

 

Taking control of systemic inflammation is a meaningful way to support your health and prevent future complications. Small, consistent adjustments to your daily routine can have a lasting impact on your well-being. Whether through dietary choices, lifestyle improvements, or alternative treatments, addressing inflammation empowers you to lead a healthier, more balanced life. Commit to these changes today to enhance both your quality of life and overall health.

Stay informed on the latest advancements in stem cell research and therapies by visiting Stem Cell Clinic. Explore their comprehensive articles and updates to understand how these innovations could impact your health.

 

Image: Freepik

Pliant Therapeutics to Participate in Upcoming Investor Events

SOUTH SAN FRANCISCO, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following December investor events.

See the rest here:
Pliant Therapeutics to Participate in Upcoming Investor Events